The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
2,585 - 3,795 jobs Number of planned job losses
Announcement Date
6 August 2015
Employment effect (start)
1 July 2015
Foreseen end date
31 December 2016
Description
US pharmaceutical company Merck & Co. has announced that job losses are set to continue as part of two major restructuring programmes. Merck has already eliminated more than 36,000 positions since 2010.
Under a programme announced in 2010 following the company's merger with the Schering-Plough Corporation, Merck & Co. has already eliminated 29,160 positions via redundancies, a reduction in the number of contractors and by not filling vacant positions. The company has now announced that approximately 2,585 jobs remain to be cut under the programme. The cuts will mostly affect workers in manufacturing, and are linked to on-going factory closures. They are expected to be completed by the end of 2016. According to media sources, most of the cuts will be realised via the sale of two plants, one in Italy and one in France.
Under a second restructuring programme first announced in 2013, Merck & Co. intends to reduce its global workforce by 8.500 by the end of 2015. The job losses are focused on sales and administrative positions and positions at the company's headquarters, as well as research and development. As of 30 June 2015, 7,290 positions had been eliminated, suggesting that further job losses may follow before the end of the year.
Merck & Co. had approximately 69,000 employees as of 30 June 2015.
Sources
13 August 2015: Fierce Pharma Manufacturing
6 August 2015: Merck SEC filing
Citation
Eurofound (2015), Merck, Merger/Acquisition in World, factsheet number 84725, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/84725.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...